Efficacy, tolerability, and effects on quality of life of inhaled salmeterol and oral theophylline in patients with mild-to-moderate chronic obstructive pulmonary disease
- 31 December 1998
- journal article
- clinical trial
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 20 (6), 1130-1148
- https://doi.org/10.1016/s0149-2918(98)80109-4
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPDEuropean Respiratory Journal, 1998
- Effects of regular salmeterol on lung function and exercise capacity in patients with chronic obstructive airways disease.Thorax, 1996
- What role for theophylline?Thorax, 1994
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- A Randomized, Controlled Trial of Theophylline in Patients with Severe Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 1989
- Dose response relation to oral theophylline in severe chronic obstructive airways disease.BMJ, 1988
- Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.Thorax, 1988
- Acute response to bronchodilator. An imperfect guide for bronchodilator therapy in chronic airflow limitationArchives of Internal Medicine, 1988
- The MOS Short-form General Health SurveyMedical Care, 1988
- Treatment of chronic obstructive pulmonary disease with orally administered theophylline. A double-blind, controlled studyPublished by American Medical Association (AMA) ,1980